The store will not work correctly when cookies are disabled.
3-((E)-2-Pyridin-2-yl-vinyl)-1H-indole
ID: ALA171548
PubChem CID: 44381752
Max Phase: Preclinical
Molecular Formula: C15H12N2
Molecular Weight: 220.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C(=C/c1c[nH]c2ccccc12)\c1ccccn1
Standard InChI: InChI=1S/C15H12N2/c1-2-7-15-14(6-1)12(11-17-15)8-9-13-5-3-4-10-16-13/h1-11,17H/b9-8+
Standard InChI Key: OZPYZRJHDWCCQM-CMDGGOBGSA-N
Molfile:
RDKit 2D
17 19 0 0 0 0 0 0 0 0999 V2000
0.4917 -2.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4917 -1.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9875 -1.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7500 -0.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2958 -1.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2958 -2.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5542 -0.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6250 0.7583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8125 0.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0083 -1.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8792 1.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0083 -2.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2625 1.1958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7208 -1.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3167 2.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7208 -2.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 1.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 1 1 0
4 2 1 0
5 6 1 0
6 1 1 0
7 4 2 0
8 9 2 0
9 7 1 0
10 5 2 0
11 8 1 0
12 6 2 0
13 9 1 0
14 16 2 0
15 17 1 0
16 12 1 0
17 13 2 0
2 5 1 0
10 14 1 0
11 15 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 220.28 | Molecular Weight (Monoisotopic): 220.1000 | AlogP: 3.73 | #Rotatable Bonds: 2 |
Polar Surface Area: 28.68 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.66 | CX LogP: 3.43 | CX LogD: 3.43 |
Aromatic Rings: 3 | Heavy Atoms: 17 | QED Weighted: 0.70 | Np Likeness Score: -0.68 |
References
1. Madge D, Hazelwood R, Iyer R, Jones H, Salter M. (1996) Novel tryptophan dioxygenase inhibitors and combined tryptophan dioxygenase/5-HT reuptake inhibitors, 6 (7): [10.1016/0960-894X(96)00124-2] |
2. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R.. (2011) Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators., 54 (15): [PMID:21726069] [10.1021/jm2006782] |